Influence
July 16, 2020

Regenstrief research scientist shares ICU experience during Side Effects COVID-19 panel

Regenstrief research scientist Sikandar Khan, D.O., shared his perspective from working in the intensive care unit (ICU) in the midst of the COVID-19 outbreak during a panel hosted by Side Effects Public Media and Indiana Public Broadcasting.

Dr. Khan has been treating patients in the ICU at Indiana University Health Methodist Hospital throughout the COVID-19 pandemic. He spoke about how data has helped guide decisions in the ICU, allowing clinicians to anticipate surges in cases and plan for equipment and personnel needs.

He also talked about the potentially long recovery COVID-19 survivors face. Patients who need intensive care, especially those who are put on ventilators, are at risk for post intensive care syndrome. This can affect the patient’s body as well as the mind. Dr. Khan said he and his colleagues are closely watching to see what recovery will look like for COVID-19 patients.

Dr. Khan also lauded his colleagues for adapting to the stressful situation and their tireless work to take care of patients. He urged everyone to continue taking precautions, including social distancing and wearing masks.

Watch the entire panel here

Related News

(From left to right) Dr. Brian Dixon, Dr. Sanji De Sylva and Isaac Vetter. Photo credit: Svetlana Efimova

Regenstrief experts advance global dialogue on digital health and interoperability at forum in Dubai

Regenstrief informaticians joined global leaders who shared their expertise at the 8th ZIMAM Digital Health Forum November 5-6, in

Regenstrief researchers join national stage to advance aging and gerontology research

Regenstrief Institute research scientists joined leading experts from across the nation at the Gerontological Society of America (GSA) 2025

illustration of the combination of interventions used in the D3 pragmatic clinical trial

Zero-cost, AI-driven digital detection identifies Alzheimer’s and related dementias without additional clinician time

Few primary care practices are designed for the timely detection of Alzheimer’s disease and related dementias. The limited time